190 related articles for article (PubMed ID: 10443724)
1. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.
Beerlage HP; van Leenders GJ; Oosterhof GO; Witjes JA; Ruijter ET; van de Kaa CA; Debruyne FM; de la Rosette JJ
Prostate; 1999 Apr; 39(1):41-6. PubMed ID: 10221265
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
[TBL] [Abstract][Full Text] [Related]
4. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
5. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
6. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
7. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
8. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
9. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate.
Van Leenders GJ; Beerlage HP; Ruijter ET; de la Rosette JJ; van de Kaa CA
J Clin Pathol; 2000 May; 53(5):391-4. PubMed ID: 10889823
[TBL] [Abstract][Full Text] [Related]
10. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
11. Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application.
Madersbacher S; Kratzik C; Marberger M
Ultrason Sonochem; 1997 Apr; 4(2):175-9. PubMed ID: 11237038
[TBL] [Abstract][Full Text] [Related]
12. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
13. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
14. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report.
Uchida T; Sanghvi NT; Gardner TA; Koch MO; Ishii D; Minei S; Satoh T; Hyodo T; Irie A; Baba S
Urology; 2002 Mar; 59(3):394-8; discussion 398-9. PubMed ID: 11880077
[TBL] [Abstract][Full Text] [Related]
15. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.
Chaussy C; Thüroff S
Curr Urol Rep; 2003 Jun; 4(3):248-52. PubMed ID: 12756090
[TBL] [Abstract][Full Text] [Related]
16. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer.
Rebillard X; Gelet A; Davin JL; Soulie M; Prapotnich D; Cathelineau X; Rozet F; Vallancien G
J Endourol; 2005; 19(6):693-701. PubMed ID: 16053358
[TBL] [Abstract][Full Text] [Related]
17. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
18. Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
Madersbacher S; Pedevilla M; Vingers L; Susani M; Marberger M
Cancer Res; 1995 Aug; 55(15):3346-51. PubMed ID: 7542168
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer: transrectal high-intensity focused ultrasound for the treatment of local recurrence after radical prostatectomy or radiotherapy].
Tasso M; Varvello F; Ferrando U
Urologia; 2009; 76(2):73-6. PubMed ID: 21086300
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
Urologiia; 2007; (6):39-44. PubMed ID: 18649659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
